Results 191 to 200 of about 4,731,590 (293)

Long‐Term Clinical Response After Low‐Dose and Short‐Duration Cemiplimab Therapy in a Patient With Xeroderma Pigmentosum in Nepal

open access: yesJEADV Clinical Practice, EarlyView.
Capsule Summary Xeroderma pigmentosum (XP) is associated with a high risk of multiple and aggressive cutaneous squamous cell carcinomas (CSCCs). The immune checkpoint inhibitor cemiplimab has been approved in advanced, unresectable, and/or metastatic CSCCs.
Sudip Parajuli   +5 more
wiley   +1 more source

Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Plasma cell mucositis (PCM) is a rare, chronic inflammatory condition of mucosal surfaces that is likely underdiagnosed and underreported, with limited data on its clinical characteristics, extracavitary involvement, and treatment outcomes.
Miguel A. Aristizabal‐Torres   +4 more
wiley   +1 more source

Dental School Biopsy Education to Promote Access to Care and Early Detection

open access: yes
Journal of Dental Education, EarlyView.
Peter E. Varela   +2 more
wiley   +1 more source

Depth of Invasion Predicts Vocal Fold Motility and Muscle Invasion in Glottic Carcinoma

open access: yesThe Laryngoscope, EarlyView.
To determine whether depth of invasion (DOI) provides an objective surrogate for vocal fold motility and vocal muscle invasion in glottic squamous cell carcinoma. Methods and Results: In derivation and external validation cohorts, radiologic DOI strongly correlated with pathologic DOI and accurately predicted altered vocal fold motility and muscle ...
Elisa Bellini   +22 more
wiley   +1 more source

Effects of NDURE on Timely Adjuvant Radiotherapy in HNSCC: Subgroup Analysis of an RCT

open access: yesThe Laryngoscope, EarlyView.
In this subgroup analysis of a randomized clinical trial of 145 patients with locally advanced head and neck squamous cell carcinoma, the enhanced navigation‐based intervention NDURE improved initiation of timely postoperative radiation therapy (PORT) relative to usual care across nearly all demographic and clinical subgroups, including patients with ...
Jonathan M. Hughes   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy